BlackRock ESG Capital Allocation Term Trust
corporate_fare Company Profile
BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT) is a publicly traded company in the Unknown sector. Wiseek has independently scored 23 items for ECAT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-06-29, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for ECAT spans SCHEDULE 13D/A, DEFA14A, DFAN14A, DEFC14A.
Recent high-impact activity:
- Activist Investor Saba Capital Reduces Stake by $19 Million
- Activist Investor Saba Capital Sells $17.85M in Shares Amidst Proxy Battle
- BlackRock Trust Actively Solicits Votes for Board Nominees, Citing Proxy Advisor Support
- BlackRock ESG Capital Allocation Term Trust Board Gains Key Proxy Advisor Support Against Activist
- Glass Lewis Recommends Voting for ECAT's Board Nominees, Rejects Activist Slate
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 104,062 shares in ECAT as of the October 30, 2026 settlement, a 58.1% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 11.2% of ECAT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.